Penny Stock Watch List: VuMee Inc. (OTC:VUME), Advanced Cell Technology Inc. (OTC:ACTC),Amarantus BioScience, Inc. (AMBS) and Generex Biotechnology Corp. (GNBT) Have Been Added to Growing Stock Report's Watch List

New York, NY -- (SBWIRE) -- 01/09/2013 -- Growing Stock Report iniates an OTC Penny Stock Watch List and Investor Polls for the following stocks: VuMee Inc. (OTC:VUME), Advanced Cell Technology Inc. (OTC:ACTC),Amarantus BioScience, Inc. (AMBS) and Generex Biotechnology Corp. (GNBT).

VuMee Inc. (OTC:VUME) As of This Writing UP (+105.76%) on 15,101,520 Shares Traded.

VuMee Inc. (OTC:VUME) a company that provides VuMee, a video uploads monetizing entertainments elite application for iOS or Android mobile device users to record, name, upload, and share videos of celebrities and brands is up over 105% this morning which has prompted Growing Stock Report to Add VuMee Inc. (OTC:VUME) to their Penny Stock Watch List.

Get VUME Poll & Consensus Report Here: http://www.growingstockreport.com/Survey.aspx?stock=VUME

Advanced Cell Technology Inc. (OTC:ACTC) As of This Writing is down (-6.46) on 8,299,515 Shares Traded.

Advanced Cell Technology Inc. (OTC:ACTC) recently announced that investigators for the Company’s Phase I/II clinical trials for Stargardt’s macular dystrophy (SMD) and dry age-related macular degeneration (dry AMD) have observed evidence of engraftment of the transplanted human embryonic stem cell (hESC)-derived retinal pigment epithelial (RPE) cells and visual acuity gain in patients treated over the 18 months since the trials were first initiated, which has prompted Growing Stock Report to Add Advanced Cell Technology Inc. (OTC:ACTC) to their Penny Stock Watch List.

Get ACTC Poll & Consensus Report Here: http://www.growingstockreport.com/Survey.aspx?stock=ACTC

Amarantus BioScience, Inc. (OTC:AMBS) As of This Writing is (+3.91%) on 6,602,167 Traded.

Amarantus BioScience, Inc. (OTC:AMBS) a biotechnology company discovering and developing treatments and diagnostics for diseases associated with protein misfolding and apoptosis centered around its patented therapeutic protein Mesencephalic Astrocyte-derived Neurotrophic Factor (MANF), today presented positive preclinical efficacy data for MANF in a neurorestoration 6-hydroxydopamine (6-OHDA) rat model of Parkinson's disease, which has prompted Growing Stock Report to Add Advanced Cell Technology Inc. Amarantus BioScience, Inc. (OTC:AMBS) to their Penny Stock Watch List.

Get AMBS Poll & Consensus Report Here: http://www.growingstockreport.com/Survey.aspx?stock=AMBS

Generex Biotechnology Corp. (OTC:GNBT) As of This Writing is down (-13.66%) on 2,434,081 Shares Traded.

Generex Biotechnology Corp. (OTC:GNBT) a development stage company, that engages in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases is down nearly 78% from where it was this same time last year which has prompted Growing Stock Report to Add Generex Biotechnology Corp. (OTC:GNBT) to their Penny Stock Watch List.

Get GNBT Poll & Consensus Report Here: http://www.growingstockreport.com/Survey.aspx?stock=GNBT

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com